Allmed Medical Products Co., Ltd (002950.SZ)
CNY 8.6
(5.01%)
CNY 8.6
(5.01%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.75 Billion | 4.21 Billion | 2.92 Billion | 3.83 Billion | 2.35 Billion | 2.02 Billion |
| Cost of Revenue | 2.09 Billion | 2.79 Billion | 2.04 Billion | 2.23 Billion | 1.55 Billion | 1.39 Billion |
| Gross Profit | 657.93 Million | 1.41 Billion | 881.5 Million | 1.59 Billion | 797.11 Million | 636.27 Million |
| Operating Expenses | 488.87 Million | 539.09 Million | 423.23 Million | 353.63 Million | 381.61 Million | 320.68 Million |
| Selling, General and Administrative Expenses | 386.07 Million | 182.43 Million | 140.65 Million | 90.08 Million | 192.18 Million | 151.86 Million |
| Research and Development Expenses | 77.36 Million | 107.73 Million | 94.57 Million | 118.12 Million | 59.71 Million | 49.73 Million |
| Other Expenses | 25.43 Million | 248.92 Million | 188 Million | 145.42 Million | 129.72 Million | -1.21 Million |
| Cost and Expenses | 2.58 Billion | 3.33 Billion | 2.46 Billion | 2.58 Billion | 1.93 Billion | 1.71 Billion |
| Operating Income | 180 Million | 525.07 Million | 505.87 Million | 1.34 Billion | 390.54 Million | 277.59 Million |
| Interest Expense | 33.19 Million | 35.47 Million | 17.18 Million | 17.66 Million | 37.42 Million | 36.01 Million |
| Income Tax Expense | 64.82 Million | 80.25 Million | 73.53 Million | 178.2 Million | 69.95 Million | 50.07 Million |
| Earnings before Tax | 169.04 Million | 484.9 Million | 505.49 Million | 1.33 Billion | 394.15 Million | 276.38 Million |
| Net Income | 110.39 Million | 406.79 Million | 431.21 Million | 1.15 Billion | 325.81 Million | 227.78 Million |
| Earnings Per Share Basic | 0.17 | 0.64 | 0.68 | 1.83 | 0.51 | 0.41 |
| Earnings Per Share Diluted | 0.17 | 0.64 | 0.68 | 1.83 | 0.51 | 0.41 |
| Weighted Average Shares Outstanding | 633.38 Million | 633.26 Million | 633.26 Million | 633.26 Million | 633.26 Million | 561.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 633.38 Million | 633.26 Million | 633.26 Million | 633.26 Million | 633.26 Million | 561.22 Million |
| Gross Margin | 0.24 | 0.34 | 0.30 | 0.42 | 0.34 | 0.31 |
| EBIT Margin | 0.15 | 0.19 | 0.23 | 0.38 | 0.24 | 0.21 |
| Profit Margin | 0.04 | 0.10 | 0.15 | 0.30 | 0.14 | 0.11 |
| EBITDA | 409.86 Million | 696.67 Million | 672.87 Million | 1.49 Billion | 558.4 Million | 427.58 Million |
| Earnings Before Tax Margin | 0.07 | 0.12 | 0.17 | 0.35 | 0.17 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 863.05 Million | 830.16 Million | 741.8 Million | 732.31 Million | 2.73 Billion | 591.56 Million |
| Cost of Revenue | 638.46 Million | 612.32 Million | 531.56 Million | 591.22 Million | 2.06 Billion | 433.53 Million |
| Gross Profit | 224.59 Million | 217.84 Million | 210.24 Million | 141.08 Million | 672.31 Million | 158.03 Million |
| Operating Expenses | 126.15 Million | 99.73 Million | 102.21 Million | 173.81 Million | 492.31 Million | 119.85 Million |
| Selling, General and Administrative Expenses | 104.84 Million | 81.25 Million | 83.07 Million | 75.5 Million | - | 232.18 Million |
| Research and Development Expenses | 19.04 Million | 18.71 Million | 18.45 Million | 16.94 Million | - | 22.02 Million |
| Other Expenses | -2.26 Million | 226.43 Thousand | -684.77 Thousand | -81.36 Million | -102.3 Million | 12.87 Thousand |
| Cost and Expenses | 764.62 Million | 712.06 Million | 633.78 Million | 765.04 Million | 2.55 Billion | 553.38 Million |
| Operating Income | 98.43 Million | 118.1 Million | 108.02 Million | -32.72 Million | 180 Million | -3991.85 |
| Interest Expense | 6.33 Million | 6.68 Million | 8.1 Million | 7.27 Million | 31.86 Million | 7.96 Million |
| Income Tax Expense | 16.92 Million | 27.36 Million | 20.53 Million | 12.46 Million | 64.82 Million | 9.82 Million |
| Earnings before Tax | 98.91 Million | 125.66 Million | 111.95 Million | -37.22 Million | 159.17 Million | 8882.02 |
| Net Income | 78.16 Million | 93.11 Million | 93.87 Million | -40 Million | 110.39 Million | -6.63 Million |
| Earnings Per Share Basic | 0.13 | 0.15 | 0.15 | -0.06 | - | -0.01 |
| Earnings Per Share Diluted | 0.13 | 0.15 | 0.15 | -0.06 | - | -0.01 |
| Weighted Average Shares Outstanding | 620.74 Million | 620.74 Million | 633.26 Million | 633.26 Million | 633.26 Million | 633.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 620.74 Million | 620.74 Million | 633.26 Million | 633.26 Million | 633.26 Million | 633.26 Million |
| Gross Margin | 0.26 | 0.26 | 0.28 | 0.19 | 0.25 | 0.27 |
| EBIT Margin | 0.12 | 0.21 | 0.17 | 0.04 | - | 0.03 |
| Profit Margin | 0.09 | 0.11 | 0.13 | -0.05 | 0.04 | -0.01 |
| EBITDA | 105.24 Million | 176.16 Million | 127.7 Million | 25.67 Million | - | 16.38 Million |
| Earnings Before Tax Margin | 0.11 | 0.14 | 0.15 | -0.04 | 0.07 | -0.00 |
XCX
RGA
600569
FREJN
FVI
600083